{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:29:59Z","timestamp":1648783799281},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1157\/13076461","type":"journal-article","created":{"date-parts":[[2005,6,22]],"date-time":"2005-06-22T12:21:44Z","timestamp":1119442904000},"page":"41-45","source":"Crossref","is-referenced-by-count":1,"title":["Interrupci\u00f3n del tratamiento antirretroviral en pacientes con infecci\u00f3n cr\u00f3nica por el virus de la inmunodeficiencia humana"],"prefix":"10.1016","volume":"125","author":[{"given":"Concepci\u00f3n","family":"Amador","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Pasquau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa F.","family":"Ruiz de Apodaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13076461_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbility and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1157\/13076461_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00002030-199712000-00003","article-title":"Impact of protease inhibitors on AIDS: defining events and hospitalizations in 10 French AIDS reference centers","volume":"11","author":"Mouton","year":"1997","journal-title":"AIDS"},{"key":"10.1157\/13076461_bib3","first-page":"169","article-title":"Evoluci\u00f3n de la mortalidad y supervivencia del SIDA en Barcelona (1981-1997)","volume":"113","author":"Garc\u00eda de Olalla","year":"1999","journal-title":"Med Clin Barc"},{"key":"10.1157\/13076461_bib4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0140-6736(05)60532-6","article-title":"Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study","volume":"352","author":"Plana","year":"1998","journal-title":"Lancet"},{"key":"10.1157\/13076461_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/35035103","article-title":"Immune control of HIV-1 after early treatment of acute infection","volume":"407","author":"Rosemberg","year":"2000","journal-title":"Nature"},{"key":"10.1157\/13076461_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1371\/journal.pmed.0010036","article-title":"Limited durability of viral control following treated acute HIV infection","volume":"1","author":"Kaufmann","year":"2004","journal-title":"PloS Med"},{"key":"10.1157\/13076461_bib7","author":"Mir\u00f3","year":"2002","journal-title":"Seattle"},{"key":"10.1157\/13076461_bib8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archinte.163.10.1220","article-title":"A prospective trial of structured treatment interruptions in human immunodeficiency virus infection","volume":"163","author":"Fagard","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1157\/13076461_bib9","article-title":"Interruption\/stopping antiretroviral therapy and the risk of clinical disease: results from the EuroSIDA Study. 9th Conference on Retrovirus and Opportunistics Infections. [abstract 48]","author":"Lundgren","year":"2002","journal-title":"Seattle"},{"key":"10.1157\/13076461_bib10","doi-asserted-by":"crossref","first-page":"13288","DOI":"10.1073\/pnas.221452198","article-title":"Structured antiretroviral treatment interruptions in chronically HIV-1 infected subjets","volume":"98","author":"Ortiz","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1157\/13076461_bib11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJM200102153440702","article-title":"Virologic and inmunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV\u2013infected patients with detectable viremia","volume":"344","author":"Deeks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13076461_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa035103","article-title":"Structured treatment interrption in patients with multidrug-resistant human immunodeficiency virus","volume":"349","author":"Lawrence","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13076461_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00002030-200401230-00011","article-title":"Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)","volume":"18","author":"Katlama","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13076461_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00002030-200402200-00010","article-title":"Effect of prolonged discontinuatio of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial","volume":"18","author":"Maggiolo","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13076461_bib15","first-page":"RR17","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR","volume":"41","year":"1992","journal-title":"Morb Mortal Wklt Rep"},{"key":"10.1157\/13076461_bib16","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1128\/JVI.76.20.10169-10176.2002","article-title":"Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy","volume":"76","author":"Oxenius","year":"2002","journal-title":"J Virol"},{"issue":"15","key":"10.1157\/13076461_bib17","first-page":"161","article-title":"Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters","volume":"98","author":"Dybul","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1157\/13076461_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1086\/376535","article-title":"Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters","volume":"188","author":"Dybul","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1157\/13076461_bib19","series-title":"Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections [abstract 64]","article-title":"HIVNAT 001.4: a prospective randomized trial of structured treatment interruption in patients with chronic HIV infection","author":"Ananworanich","year":"2003"},{"key":"10.1157\/13076461_bib20","series-title":"Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections [abstract 65]","article-title":"A multi-center, randomized controlled clinical trial of continuous versus intermittent HAART guided by CD4+ Tcell counts and plasma HIV-1 RNA levels","author":"Ruiz","year":"2003"},{"key":"10.1157\/13076461_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00002030-199904160-00008","article-title":"HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment","volume":"13","author":"Neumann","year":"1999","journal-title":"AIDS"},{"key":"10.1157\/13076461_bib22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1086\/379514","article-title":"Prolonged treatment interruptions after immunologic response to highly active antiretroviral therapy","volume":"37","author":"Tarwater","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13076461_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM199508173330710","article-title":"Time to hit HIV, early and hard","volume":"333","author":"Ho","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1157\/13076461_bib24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0025-7753(02)72462-7","article-title":"Interrupci\u00f3n del tratamiento antirretroviral en la pr\u00e1ctica cl\u00ednica","volume":"118","author":"Rodr\u00edguez-Guardado","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13076461_bib25","series-title":"Program and abstracts of the XIV International AIDS Conference ThOrB1440 [abstract]","article-title":"Treatment discontinuation in patients who started antiretroviral therapy following the 1996 IAS-USA. Recomendations. A prospective randomized trial","author":"Krolewiecki","year":"2002"},{"key":"10.1157\/13076461_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00002030-200404300-00005","article-title":"Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia","volume":"18","author":"Karlsson","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13076461_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1570162043485077","article-title":"CD8+ T-cells: funtion and response to HIV infection","volume":"1","author":"Gulzar","year":"2004","journal-title":"Curr HIV Res"},{"key":"10.1157\/13076461_bib28","series-title":"The 2nd IAS Conference in HIV Pathogenesis and treatment [Abstract 601]","article-title":"A prospective, randomised trial of treatment discontinuation after inmunologic respose to HAART","author":"Moreno","year":"2003"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775305719400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775305719400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T05:56:17Z","timestamp":1548395777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775305719400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0025775305719400"],"URL":"https:\/\/doi.org\/10.1157\/13076461","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}